跳至主要内容
临床试验/ISRCTN46078697
ISRCTN46078697已完成未知

Prevention Of Morbidity in Sickle cell disease 2a - pilot phase (POMS 2a): Improvement of pain and quality of life in patients with sickle cell disease with nocturnal oxygen therapy or auto-adjusting continuous positive pressure: pilot phase

niversity Hospital Southampton NHS Foundation Trust (UK)0 个研究点目标入组 21 人开始时间: 2014年7月18日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
21

研究概览

简要总结

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Age over 8 years
  • 2. Informed consent with assent in accordance with the institutional policies (UK ethical committee) and European or US Federal guidelines
  • 3. Sickle cell haemoglobin (HbSS) diagnosed by standard techniques
  • 4. Able to speak and understand English
  • 5. Patient or parent/guardian able to use smart phone

排除标准

  • 1. Patient already on overnight respiratory support or has used it in the past
  • 2. Hospital admission for acute sickle complication within the past 1 month
  • 3. Patient with > 6 admissions for acute sickle complications within the past 12 months
  • 4. Existing Respiratory Failure
  • 5. Decompensated Cardiac Failure
  • 6. History of Severe Epistaxis
  • 7. Transsphenoidal

研究者

发起方
niversity Hospital Southampton NHS Foundation Trust (UK)

相似试验

Improvement of pain and quality of life in patients... | 临床试验